• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.07% Nasdaq Up 0.32%

    Aegerion Pharmaceuticals, Inc. (AEGR)

    -NasdaqGS
    17.66 Down 0.10(0.56%) Aug 28, 4:00PM EDT
    Add to Portfolio
    Prev Close:17.76
    Open:17.62
    Bid:N/A
    Ask:18.60 x 1000
    1y Target Est:24.14
    Beta:0.938034
    Earnings Date:Oct 28 - Nov 2 (Est.)
    Day's Range:17.30 - 17.90
    52wk Range:16.68 - 36.19
    Volume:587,845
    Avg Vol (3m):556,128
    Market Cap:505.44M
    P/E (ttm):N/A
    EPS (ttm):-1.43
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for AEGR

    Comparison

    Symbol% ChgMkt Cap
    AEGRDown 0.56%505.44M
    AZNUp 0.19%80.06B
    PFEDown 1.80%201.43B
    MRKUp 0.76%155.96B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):2.32
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.99
    Quarterly EPS Est (Sep-15) :-0.42
    Mean Recommendation*:2.9
    PEG Ratio (5 yr expected):-1.75

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Aegerion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies for patients with debilitating rare diseases in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback